Brandes AA - Search Results

1

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma.

Brandes AA, Nicolardi L, Tosoni A, Gardiman M, Iuzzolino P, Ghimenton C, Reni M, Rotilio A, Sotti G, Ermani M. Brandes AA, et al. Neuro Oncol. 2006 Jul;8(3):253-60. doi: 10.1215/15228517-2006-005. Epub 2006 May 24. Neuro Oncol. 2006. PMID: 16723632 Free PMC article.

2

Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.

Brandes AA, Rigon A, Zampieri P, Scelzi E, Amistà P, Berti F, Rotilio A, Gardiman M, Fiorentino MV. Brandes AA, et al. J Neurooncol. 1996 Dec;30(3):247-55. doi: 10.1007/BF00177276. J Neurooncol. 1996. PMID: 8943100 Clinical Trial.

3

Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

Brandes AA, Scelzi E, Zampieri P, Rigon A, Rotilio A, Amista P, Berti F, Fiorentino MV. Brandes AA, et al. Am J Clin Oncol. 1997 Aug;20(4):364-7. doi: 10.1097/00000421-199708000-00008. Am J Clin Oncol. 1997. PMID: 9256890 Clinical Trial.

4

Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study.

Brandes AA, Scelzi E, Salmistraro G, Ermani M, Carollo C, Berti F, Zampieri P, Baiocchi C, Fiorentino MV. Brandes AA, et al. Eur J Cancer. 1997 Sep;33(10):1592-6. doi: 10.1016/s0959-8049(97)00167-6. Eur J Cancer. 1997. PMID: 9389920

5

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.

Brandes AA, Rigon A, Zampieri P, Ermani M, Carollo C, Altavilla G, Turazzi S, Chierichetti F, Florentino MV. Brandes AA, et al. Cancer. 1998 Jan 15;82(2):355-61. doi: 10.1002/(sici)1097-0142(19980115)82:2<362::aid-cncr17>3.0.co;2-x. Cancer. 1998. PMID: 9445194 Clinical Trial.

6

Unusual nasal and orbital involvement of glioblastoma multiforme: a case report and review of the literature.

Brandes A, Carollo C, Gardiman M, Scelzi E, Bottin R, Zampieri P, Rigon A, Fiorentino MV. Brandes A, et al. J Neurooncol. 1998 Jan;36(2):179-83. doi: 10.1023/a:1005708107153. J Neurooncol. 1998. PMID: 9525817 Review.

7

Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.

Brandes AA, Ermani M, Turazzi S, Scelzi E, Berti F, Amistà P, Rotilio A, Licata C, Fiorentino MV. Brandes AA, et al. J Clin Oncol. 1999 Feb;17(2):645-50. doi: 10.1200/JCO.1999.17.2.645. J Clin Oncol. 1999. PMID: 10080610 Clinical Trial.

8

Chemotherapy in patients with recurrent and progressive central neurocytoma.

Brandes AA, Amistà P, Gardiman M, Volpin L, Danieli D, Guglielmi B, Carollo C, Pinna G, Turazzi S, Monfardini S. Brandes AA, et al. Cancer. 2000 Jan 1;88(1):169-74. doi: 10.1002/(sici)1097-0142(20000101)88:1<169::aid-cncr23>3.0.co;2-7. Cancer. 2000. PMID: 10618620

9

Temozolomide in patients with high grade gliomas.

Brandes AA, Pasetto LM, Vastola F, Monfardini S. Brandes AA, et al. Oncology. 2000 Sep;59(3):181-6. doi: 10.1159/000012158. Oncology. 2000. PMID: 11053983 Review.

10

Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.

Lumachi F, Brandes AA, Ermani M, Bruno G, Boccagni P. Lumachi F, et al. Among authors: brandes aa. Anticancer Res. 2000 Nov-Dec;20(6C):4751-5. Anticancer Res. 2000. PMID: 11205212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters